Lucid Diagnostics
LUCD
72 hedge funds and large institutions have $21.9M invested in Lucid Diagnostics in 2025 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 19 increasing their positions, 6 reducing their positions, and 9 closing their positions.
256% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 9
217% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 6
55% more capital invested
Capital invested by funds: $14.1M → $21.9M (+$7.78M)
47% more funds holding
Funds holding: 49 → 72 (+23)
6.71% more ownership
Funds ownership: 10.81% → 17.52% (+6.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$4.64M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.18M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.65M |
| 4 |
State Street
Boston,
Massachusetts
|
+$747K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$630K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.48M |
| 2 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$629K |
| 3 |
SS
Sunbelt Securities
Houston,
Texas
|
-$387K |
| 4 |
Millennium Management
New York
|
-$304K |
| 5 |
Renaissance Technologies
New York
|
-$279K |
LUCD Hedge Fund Activity: Q2 2025 in Review
72 of the 7,598 institutional investors tracked by Wall St. Rank reported a position in Lucid Diagnostics (LUCD) for Q2 2025, worth a combined $21.9M — up 55% from $14.1M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new LUCD positions and 9 closed out — a net gain of 23 holders — while 19 added to existing stakes and 6 trimmed.
The largest buyer was BlackRock, adding an estimated $4.64M. The largest seller was Alyeska Investment Group, cutting an estimated $1.48M.
- 72 institutional investors held Lucid Diagnostics (LUCD) as of Q2 2025, up from 49 in Q1 2025.
- Funds reported $21.9M of Lucid Diagnostics stock for Q2 2025, up 55% quarter-over-quarter.
- 32 funds opened new Lucid Diagnostics positions in Q2 2025 and 9 closed out, a net change of +23 holders.
- The largest Lucid Diagnostics buyer in Q2 2025 was BlackRock, an estimated $4.64M added.
- The largest Lucid Diagnostics seller in Q2 2025 was Alyeska Investment Group, an estimated $1.48M sold.
Based on aggregated 13F filings for Q2 2025.